Liminatus Pharma Competitors and Similar CompaniesClear all
Liminatus Pharma's competitors and similar companies include CEL-SCI and Topas Therapeutics.
 Liminatus Pharma Liminatus Pharma (formerly known as Iris Acquisition) is a pre‑clinical‑stage immuno‑oncology company. |  CEL-SCI CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases. |  Topas Therapeutics Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as multiple sclerosis. | |
Founding Date | Founding Date 2018 | Founding Date 1983 | Founding Date 2013 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations La Palma, US HQ | Locations Vienna, US HQ | Locations Hamburg, DE HQ Bremen, DE |
Employees | Employees 1 | Employees N/A | Employees N/A |
Financial | |||
Net income | Net income ($10.2m) (FY, 2025) | Net income ($25.4m) (FY, 2025) | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
CEL-SCI
HQ
Vienna, US
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
View companyTopas Therapeutics
HQ
Hamburg, DE
Topas Therapeutics is a development stage company that intends to build neuro based pipeline of clinical-stage development therapeutics and projects to treat autoimmune diseases such as multiple sclerosis.
View company